Nanox Expands into Costa Rica with Nanox.ARC Distribution Agreement

Nanox (NASDAQ: NNOX) has signed a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement grants SOLME responsibility for marketing, distribution, installation, training, and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country’s principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration.

This move represents Nanox’s third Latin American market this year, following Argentina and Peru. The expansion into Costa Rica is significant because it underscores Nanox’s strategy to penetrate emerging markets where access to advanced medical imaging is often limited. By partnering with SOLME, which has an established relationship with the CCSS, Nanox gains a direct channel to a key public healthcare provider, potentially accelerating adoption of its technology. The CCSS is responsible for managing public hospitals and clinics across Costa Rica, and its endorsement or procurement could serve as a catalyst for broader use of the Nanox.ARC in the region.

The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

The agreement’s impact extends beyond Costa Rica. By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The company’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

For investors and industry observers, the Costa Rica deal signals Nanox’s continued commitment to global expansion despite regulatory hurdles. The initial six-month proof-of-concept registration period allows for real-world validation of the Nanox.ARC in a new market, which could inform future regulatory strategies in other countries. Success in Costa Rica could also strengthen Nanox’s position in Latin America, where healthcare systems are increasingly seeking affordable imaging solutions to address growing demand for diagnostic services. The latest news and updates relating to NNOX are available in the company’s newsroom at https://ibn.fm/NNOX. For full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published, visit https://IBN.ai/Disclaimer.